Opus Genetics, Inc. (IRD) Discusses Topline Results From Cohort 1 of BEST1 Phase I/II Gene Therapy Trial - Slideshow (NASDAQ:IRD) 2026-09-09
· seekingalpha.com
2026-09-09. The following slide deck was published by Opus Genetics, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...